Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Neuropharmacology. 2020 Jul 24;176:108241. doi: 10.1016/j.neuropharm.2020.108241

Fig. 4:

Fig. 4:

Impact of Xie2-64 on extracellular DA in the NAc as assessed by in vivo microdialysis. A, Systemic administration of Xie2-64 dose-dependently reduces extracellular DA in the nucleus accumbens (NAc) for over two hours post-administration. B, Intra-NAc local perfusion of Xie2-64 also decreased extracellular DA in the NAc. ***p < 0.001, **p < 0.01, *p < 0.05 compared to baseline.